Skip to content

Clinical study on the treatment of decreased ovarian reserve function based on ''Kidney-Tiangui-Chongren-Uterine axis'' using Rendu Meridian-splitting medicine shop moxibustion

Clinical study on the treatment of decreased ovarian reserve function based on ''Kidney-Tiangui-Chongren-Uterine axis'' using Rendu Meridian-splitting medicine shop moxibustion

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053917
Enrollment
Unknown
Registered
2021-12-02
Start date
2021-11-30
Completion date
Unknown
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarian reserve

Interventions

Control group:1/10 Finmatone
Experimental group:Ren Du Vessel Medicine-separated Moxibustion

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Those diagnosed with decreased ovarian reserve (diagnostic criteria refer to Practical Gynecological Endocrinology, Obstetrics and Gynecology; 2. TCM syndrome differentiation is spleen-kidney-yang deficiency syndrome, kidney deficiency and blood stasis syndrome, aged 18 to 45 years, female or nationality is not limited; 3. Have not used any hormone drugs and other immune preparations in the past 3 months; 4. Those who voluntarily participated in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Congenital abnormal development of reproductive organs, primary or secondary amenorrhea caused by acquired organic lesions and injuries of reproductive organs; 2. Combined with polycystic ovary syndrome, uterine disease and other diseases; bilateral oophorectomy caused premature ovarian failure; chemotherapy-induced ovarian reserve loss; 3. Combined with serious diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system; combined with other hormone drugs; 4. Psychiatric patients; malignant tumor patients; 5. Patients with liver-kidney yin deficiency syndrome, kidney deficiency and liver stagnation syndrome, or hyperactivity of liver-yang, yin-deficiency and fire-prosperity are not suitable for moxibustion.

Design outcomes

Primary

MeasureTime frame
Symptoms and signs score;

Secondary

MeasureTime frame
Serum sex reproductive hormones;Vaginal ultrasound;Menopause Quality of Life Scale;self-rating depression scale;Blood index test;

Countries

China

Contacts

Public ContactChen Yidan

Zhejiang Hospital

chenyidan0908@vip.126.com+86 13221067998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026